Copyright
©The Author(s) 2016.
World J Clin Oncol. Oct 10, 2016; 7(5): 340-351
Published online Oct 10, 2016. doi: 10.5306/wjco.v7.i5.340
Published online Oct 10, 2016. doi: 10.5306/wjco.v7.i5.340
Figure 1 Epidermal growth factor receptor signaling along with co-activated other receptor tyrosine kinases.
EGFR: Epidermal growth factor receptor; PIK3CA: Phosphatidylinositol 3-kinase; mTOR: Mechanistic target of rapamycin.
- Citation: Sobani ZA, Sawant A, Jafri M, Correa AK, Sahin IH. Oncogenic fingerprint of epidermal growth factor receptor pathway and emerging epidermal growth factor receptor blockade resistance in colorectal cancer. World J Clin Oncol 2016; 7(5): 340-351
- URL: https://www.wjgnet.com/2218-4333/full/v7/i5/340.htm
- DOI: https://dx.doi.org/10.5306/wjco.v7.i5.340